期刊文献+

HLA-DR2与中国人1型糖尿病相关性的探讨 被引量:2

A study on the relationship between HLA-DR2 and type 1 diabetes mellitus in Chinese population
下载PDF
导出
摘要 目的 研究HLA -DR2与中国人 1型糖尿病的相关性。方法 应用序列特异引物PCR(PCR -SSP)技术检测华南地区汉族 64例 1型糖尿病 (1型DM )患者 (包括 15岁前起病组 17例 ,15~ 3 0岁起病组 3 0例以及 3 0岁后起病组 17例 )和 72例健康对照者的HLA -DR2等位基因。结果  1型DM组和对照组HLA -DR2等位基因频率分别为3 1 3 %和 3 6 6% ,差异无显著性 (P >0 0 5 )。 15岁前起病组、15~ 3 0岁起病组和 3 0岁后起病组中HLA -DR2频率分别为 17 6%、3 0 0 %和 47 1% ,各组间比较及分别与对照组比较差异均无显著性 ,但 15岁前起病组与 3 0岁后起病组比较P =0 0 5 8。HLA -DR2 1型DM组与非HLA -DR2 1型DM组比较DK及 /或DKA发生率较低 (5 5 %及 84% ,RR =0 65 )。对包括本组的 5份华人资料的联合分析显示HLA -DR2与IDDM呈弱负相关 (P <0 0 2 5 ,RR =0 65 )。结论 HLA -DR2与中国人 1型DM发病的关系仍有待大样本研究的证实 ,尤应增加儿童起病 1型糖尿病的研究。HLA -DR2与 1型糖尿病患者DK及 Objective To study the association of HLA-DR2 with type 1 diabetes mellitus(DM). Methods PCR amplification with sequence-specific primers was performed for HLA-DR2 genotyping in 64 type 1 DM patients(including 17 cases in group A with onset of diabetes before 15 years of age, 30 cases in group B between 15~30 and 17 cases in group C after 30) and 72 healthy controls. Results The frequency of HLA-DR2 in type 1 DM patients and controls was 31.3% and 36.6% respectively ( P > 0 05 ). The frequency of HLA-DR2 in group A, B and C was 17 6%, 30.0% and 47.1% respectively. The differences between any two subgroups of type 1 DM and between any subgroups of type 1 DM and control were not statistically significant ( P > 0.05 ). Comparing group A and group C resulted in P =0.058. The incidence of DK and/or DKA in the HLA-DR2 type 1 DM patients was lower than in the non-HLA-DR2 type 1 DM patients (55% and 84% respectively, P <0.025). Combined analysis showed a weak negative correlafion between HLA-DR2 and type 1 DM( P <0.025, RR=0.65, 95% CI 0.46~0.93).Conclusion To confirm the association between HLA-DR2 and type 1 DM in Chinese population, more studies with larger samples, especially in childhood onset type 1 DM patients are necessary. Furthermore, the association between HLA-DR2 and DK and/or DKA in type 1 DM patients remains to be verified.
出处 《广东医学》 CAS CSCD 2002年第4期364-366,共3页 Guangdong Medical Journal
基金 广东省科委重点技术攻关项目基金资助课题
  • 相关文献

参考文献3

二级参考文献13

  • 1桑艳梅,颜纯,朱逞,倪桂臣.HLA-DRB1和DQ基因与胰岛素依赖型糖尿病遗传易感相关性的联合研究[J].中国糖尿病杂志,1997,5(1):3-6. 被引量:11
  • 2高洪伟,洪天配,李琼芳.细胞因子与胰岛损伤[J].中国糖尿病杂志,1997,5(1):44-46. 被引量:5
  • 3[11]Trembleau S, Germann T, Gately MK, et al. The role of IL12 in the induction of organ-specfic autoimmune diseases. Immunol Today,1995,16:383-386.
  • 4[12]Mbanya JC, Sobngwi E, Mbanya DN. HLA-DRB1,-DQA1,DQB1 and DPB1 susceptibility alleles in Cameroonian type 1 diabetes patients and controls. Eur J Immunogenet, 2001,28:459-462.
  • 5[1]Singal DP, Ye M.HLA-DM polymorphisms in patients with Rheumatoid Arthritis. J Rheumatol, 1998,25:1295-1298.
  • 6[2]Cucchi-MP,Carcassi C,Sorba P, et al.Implication of HLA-DMA alleles in Corsican IDDM.Dis Markrs, 1998,14:135-141.
  • 7[3]Siegmund T,Donner H,Braun J,et al.HLA-DMA and HLA-DMB alleles in German patients with type 1 diabetes mellitus.Tissue Antigens, 1999, 54:291-294.
  • 8[4]Toussirot E,Sauvageot C,Chabod J,et al.The association of HLA-DM genes with rueumatoid arthritis in Eastern France. Hum Immunol,2000,61:303-308.
  • 9[5]Bennetts BH,Teutsch SM,Buhler MM,et al.HLA-DMB gene and HLA-DRA promoter region polymorphisms in Australian multiple sclerosis patients. Hum Immunol,1999,60:886-893.
  • 10[6]Mosyak L,Zaller DM,Wiley DC.The structure of HLA-DM,the peptide exchange catalyst that loads antigen onto class ⅡMHC molecules during antigen presentation. Immunity, 1998,9:377-383.

共引文献10

同被引文献37

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部